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ABSTRAK 
 
OBJEKTIF: Untuk membandingkan keberkesanan dan keselamatan ketamine pada dos 
tinggi berbanding gabungan ketamine dan midazolam untuk prosedur tusukan lumbar 
pada kanak-kanak berpenyakit leukemia.  
 
METODOLOGI: Sebanyak 29 orang pesakit leukemia telah menjalani pengambilan 
air tulang belakang di dalam “double blinded cross-over clinical trial”. Terdapat 2 
kumpulan iaitu kumpulan yang menerima dos tunggal ketamine ( 2mg/kg berat badan ) 
dan kumpulan yang menerima dos gabungan ketamine ( 1mg/kg berat badan ) dengan 
midazolam (0.1mg/kg berat badan) . Kesemua ubat diberi secara intravena. Hasil utama 
yang dinilai ialah masa untuk mencapai pelalian yang dikehendaki (aras 6 pelalian 
Ramsay), jangka masa menyempurnakan tusukan lumbar, masa untuk pesakit sedar 
sepenuhnya (skor pemulihan Aldrete sekurang-kurangnya 8 ) dan kesan buruk ubat.   
 
KEPUTUSAN: Dua puluh tujuh pesakit (93 peratus)  telah berjaya telah mencapai 
pelalian dengan kedua-dua kumpulan dos. Purata masa untuk mencapai pelalian dan 
kembali sedar adalah lebih cepat dengan penggunaan dos tunggal ketamine (nilai p 
<0.05). Purata masa untuk mencapai pelalian ialah 7.56 minit dengan dos tunggal 
ketamine berbanding 8.74 minit menggunakan dos gabungan KM. Purata masa untuk 
kembali sedar adalah 132 minit untuk rawatan K2 dan 173 minit untuk dos gabungan 
KM. Tidak terdapat perbezaan yang signifikan dengan masa yang diambil untuk 
menyempurnakan tusukan lumbar (nilai p = 0.06). Kesan buruk lebih kerap berlaku 
dengan dos tunggal K2 tetapi ianya tidak signifikan secara statistik (ujian McNemer 
0.250). Lapan pesakit (30 peratus) yang menerima dos tunggal K2 dan tujuh pesakit 
KM (26 peratus) memerlukan dos tambahan ketamine.  
 
KESIMPULAN: Dos tunggal ketamine 2mg per kg berat badan adalah selamat dan 
berkesan untuk prosedur tusukan lumbar pada kanak-kanak berpenyakit leukemia, 
walaubagaimana pun penambahan dos diperlukan. Pesakit perlu pemerhatian rapi 
semasa prosedur dijalankan.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ABSTRACT 
 
TITLE: Comparison of effectiveness and safety of ketamine with midazolam against 
higher dose of ketamine as procedural sedation for lumbar puncture in paediatric 
leukemic patients 
 
INTRODUCTION: Children with leukaemia undergo several invasive procedures. 
Sedation is used to make these procedures more comforting to the patient as it is 
necessary for successful outcome. However sedatives can have devastating effects. In 
our centre as well as others, combination of ketamine with midazolam has been used for 
years without specific protocol. 
 
OBJECTIVE: To compare the effectiveness and safety of combination ketamine and 
midazolam against higher dose of ketamine as procedural sedation for lumbar puncture 
in paediatric leukemic patients. 
 
METHOD: A total of 29 paediatric leukaemia patients underwent 58 lumbar punctures 
in a double blinded crossover clinical trial. The 2 regimes compared were KM regime 
who received combined intravenous midazolam 0.1mg per kg with ketamine 1mg per 
kg against K2 regime who received higher dose of intravenous ketamine i.e. 2mg per 
kg. The main outcomes measured were time to achieve the desired sedation (Ramsay 
level of sedation at 6), time to complete lumbar puncture, time to regain consciousness 
(Aldrete recovery score of at least 8) and adverse effects.  
 
RESULTS: Twenty seven patients (93%) were successfully sedated with each of the 
regimens. Mean time taken for sedation and mean time to be fully conscious after 
sedation were significantly less (p value <0.05) in K2 regime. Mean time taken for 
sedation in K2 regime was 7.56 minutes (SD 4.4) and in KM regime it was 8.74 minutes 
(SD 3.6). Mean time to be fully conscious was 132 minutes (SD 93.5) for K2 regime 
while it took 173 minutes (SD 88.8) for patients in KM regime. There is no statistically 
significant difference in mean time taken to complete LP between the 2 regimes 
(P=0.06). Two patients in K2 regime developed tachycardia and one patient had pain 
after procedure while no patient in KM regimen had either of these.  Five patients from 
either of the groups had desaturation. This was not statistically significant (McNemer 
Test 0.250) but it could be clinically relevant.  Eight patients (30%) in KM regime 
required top-up doses of ketamine and 7 patients (26%) required top-up doses of 
ketamine in K2 regime. 
 
CONCLUSION: Ketamine as a sole agent is as effective and safe as combination of 
midazolam and ketamine. It should be considered in procedural sedation for lumbar 
puncture in paediatric leukemic patients. It has faster induction and reversibility but it 
cause more adverse reactions and do not reduce time taken for lumbar puncture. An 
initial dose of 2mg per kg is safe to be used with another top up dose of 0.5mg per kg. 
Top up doses are frequently required.  
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1. INTRODUCTION 
 
1.1  Procedural sedation 
 
Procedural sedation differs in its definition. American College of Emergency 
Physicians (2004) defined procedural sedation and analgesia (PSA) as a technique of 
administering sedatives or dissociative agents with or without analgesics to induce a 
state that allows the subject to tolerate unpleasant procedures while maintaining cardio 
respiratory function (Brown et al. 2005). Level of sedation and anaesthesia is 
categorized to mild, moderate, deep sedation and general anaesthesia. The level depends 
on type and degree of stimulation required by the subject to respond. Levels of sedation 
have been well defined and approved by the American Society of Anaesthesiologists 
(ASA) and House of Delegates in 1999 (Table 1). The airway, breathing and cardiac 
function are increasingly affected as the level of sedation and anaesthesia increases. The 
old term “conscious sedation” which is used in relation to moderate sedation has been 
discouraged but is still being used in classification of level of sedation and analgesia by 
ASA (1996). The degree at which a subject is sedated is a continuum. This continuum 
from mild to moderate, deep and finally into general anaesthesia widely varies. As the 
time after administration increases it can change from mild sedation to deeper levels 
without even adding further drugs or doses. Practitioners involved in sedating children 
should be aware of this continuum. They should be well prepared for any adverse 
reactions that might arise in the deeper levels of sedation. PSA is meant for moderate 
and deep sedation and not to extend into general anaesthesias (Innes et al. 1999). 
  
Dissociative sedation is a term used to describe a trans-like cataleptic stage 
which provides sedation, analgesia and amnesia while airway protective reflexes are 
maintained including stable ventilation and cardiovascular status. Ketamine is an 
example of a drug that provides dissociative sedation where by in ketamine the 
continuum of sedation is not observed.  
 
The ideal sedation end point would be one at which the procedure can be done 
with as little distress to the patient as possible. Here patient must have the protective 
airway reflexes and stable cardiopulmonary status.  
  
 
 
 
 
 
 
 
 
 
 
 
 Table 1. Continuum of depth of Sedation: Definition of General Anaesthesia and 
Levels of Sedation/Analgesia  
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Responsiveness Normal 
response to 
verbal 
stimulation 
 
Purposeful 
response to 
verbal or tactile 
stimulation 
 
Purposeful 
response after 
repeated or 
painful 
stimulation 
Unarousable, 
even 
with painful 
stimulus 
 
Airway Unaffected No intervention 
required 
Intervention 
may be required 
Intervention 
often 
required 
 
Spontaneous 
ventilation 
Unaffected Adequate May be 
inadequate 
Frequently 
inadequate 
 
Cardiovascular 
function 
Unaffected Usually 
maintained 
Usually 
maintained 
May be 
impaired 
 
Adopted from Anesthesiology 2002;96(4):1004-17 
 
Paediatric oncology patients especially leukaemia patients must undergo several 
invasive procedures which can be quite painful. Procedural sedation and anaesthesia 
makes these procedures more comfortable to the patients. Procedural sedation is 
commonly performed outside operation theatre settings by non anaesthetists. The 
number of drugs that can be ideally used for sedation by non anaesthetists is limited and 
should be used with caution. However new drugs are being introduced and used by non 
anaesthetists and many are shown to be safe. In spite of common use of sedatives, still 
there is lack of specific guidelines for sedation to be followed in emergency 
departments as well as elective settings (Bhatt et al. 2010). Choice of sedatives is 
mostly used according to the experience of centres and those performing the procedures. 
The drug to be used and the depth of sedation required varies according to individual 
needs. Some patients need minimal anxiolytics while others require high sedation to 
control motor system as well. The reason for the lack of guidelines may be due to wide 
variability of patient conditions and pharmacokinetic and pharmacodynamic properties 
of the used drugs. There are conflicting evidence in terms of optimal route, dosage and 
drugs to be used for sedation. This has lead to wide variation in recommendations 
during PSA (Deasy and Babl 2010).  
 
The effectiveness of sedation depends on many factors such as types of drugs, 
dosage, subject route of administration and others. Effective sedation is mandatory for 
these procedures to get the best outcome. PSA is intended to result in a depressed level 
of consciousness that allows the subject to maintain oxygenation and airway control 
independently. It minimizes the unnecessary adverse effects during sedation for various 
procedures such as lumbar puncture and bone marrow aspiration. Minimizing pain 
allows patient to be less distress and more compliant to procedures. This allows treating 
doctors to perform the procedures more competently.   
 
Despite the known advantages of the procedural sedation, children remain 
deprived of adequate sedation in fear of adverse side effects and myths related to it 
(O’Brien et al. 2003). In many circumstances pain is considered a normal response. 
Many practitioners assume that children do not feel pain and do not develop memories 
of these painful procedures. In the past because of these assumptions pain in children 
during procedures has been largely ignored. Pain as a subject has not got the attention in 
research until recently (McGrath and Hillier 1992) (Zeltzer et al. 1992). Some fear the 
continuum of sedation causing deeper level of sedation while others avoid prescribing 
drugs like opioids in fear that children may become addicted to it (Elliot et al. 1987). 
Inadequate analgesics make the child to suffer from pain. Every effort should be made 
to administer adequate sedation to comfort the child (Zempsky and Cravero 2004). 
 
1.2  Leukaemia  
 
Leukaemia is the most common malignancy in children accounting for one third 
of all malignancies in this age group. Incidence of leukaemia in United States and in 
United Kingdom is 12 to 15 per 100000 (Office for National Statistics of United 
Kingdom, National Institute of Health, United States). This has been quite static during 
the last decade. According to statistics of 2003-2005 from National Cancer Council of 
Malaysia, malignancies including leukaemia in paediatrics are increasing. Prevalence of 
leukaemia in Malaysia is not far different from Western countries (Sinnah et al. 1978). 
It is a major cause of morbidity and mortality in paediatric age group. Seventy six 
percent of leukaemia in paediatric age group is acute lymphoblastic leukaemia and most 
of remaining is acute myeloblastic leukaemia (Xie, Davies 2003). Chronic myeloid 
leukaemia is rare in children. In Peninsular, Malaysia the incidence of acute 
lymphoblastic leukaemia is 433 per 100,000 population in age group between 0 to 19 
years and that of acute myeloid leukaemia is 179 (National cancer registry, Malaysia 
2003). Acute lymphoblastic leukaemia can be classified immunophenotypically into B 
and T cell type depending on cell surface cluster of differentiation. This classification is 
important in risk stratification. ALL B cell type are more common and have a better 
prognosis (O'Brien and Lacayo 2008).  
 
Cancer has been on the rise in Malaysia. It is the fourth most common cause of 
death from medically certified deaths in general population of Malaysia (Lim 2002) 
after ischemic heart disease, road traffic accidents and strokes. Treatment of cancer in 
the country still has obstacles that hinder the treatment. These include poor insight of its 
severity, seriousness of the disease and its extensive management. Lots of taboos exist 
regarding cancer among the people including well educated individuals. Several 
websites are easily accessible advertising alternative methods of so called “natural 
medicine”. They do claim that health care system are been polluted with chemicals that 
are killing. These sites also claim that health insurance companies are biased in 
sponsoring only medical treatments and should be called prescribed medicine insurance 
rather than health insurance.  Many believe cancer is not curable and treatments are not 
available. Lots of people fear the treatment and think that cancer treatments do more 
harm than benefit. Commonly patients default during the initial investigations and 
therapy. Some take the alternative treatment like traditional healers, “bomoh”, 
homeotherapy, food supplements and others. Many of them presents at late stage of the 
disease following failure of alternative treatment. These customs and practices are 
common among people with different types of cancer (Leong et al. 2009). 
 
Advances in cancer treatment leads to better prognosis. The five year survival 
rate has sharply increased over the last few decades (Gatta et al. 2005). One of the 
reasons is the availability of more effective drugs and new methods to deliver them 
(Hasle et al. 1995). Protocols of chemotherapy in HUSM for ALL patients have been 
adopted from United States Children’s cancer group and AML from BFM study group. 
Lately both ALL and AML protocols were revised based on United Kingdom’s ALL 
(UKALL) and AML protocol. Some studies show that prognosis in Malaysia for 
leukaemia is also quite similar to Western figures (Bosco and Teh 1995). A study done 
by Nasiruddin from HUSM in 2007, on 5 year survival in ALL treated in HUSM 
showed that it is comparable to developing countries like China (study done for 
dissertation and not yet published).  
 
Paediatric oncology patients require several invasive procedures for diagnosis, 
staging, monitoring and treatment. These procedures include repeated venipunctures, 
administrations of fluids and medications, lumbar punctures and bone marrow 
aspirations. Many of them are invasive, painful and cause anxiety in children and 
caretakers who are already in stress from disease and its complications. With current 
protocols of chemotherapy for leukaemia, patients undergo an average of at least one 
lumbar puncture in each month depending on the phase of chemotherapy. Even though 
LP is a short procedure, it is invasive, painful and definitely causes anxiety. The stress 
related to LP is much higher compared to its invasiveness and pain. General acceptance 
of LP is very low in Kelantan (Malaysia) population especially among Malays (Ling 
and Boey 2000). However it is better accepted by parents in cases of leukaemia. This 
could be because of severity of disease and importance of treatment. Patients, their 
families and treating paramedics are also stressed during LP (Santacroce 2002). The 
goal of procedural sedation is to sedate the subject to minimal effective duration so that 
the procedure can be done without causing pain while minimizing adverse events. 
Administering more drugs can prolong the sedation period and increase adverse events 
including time to keep subjects nil by mouth.  
 
1.3 Lumbar Puncture 
 
Lumbar puncture is a widely used medical procedure as a diagnostic as well as a 
therapeutic tool. Indication for LP varies according to clinical presentation. In the 
emergency department LP is mostly used as a diagnostic tool for meningoencephalitis. 
It is also useful in diagnosis of other conditions such as neurosyphillis and Guillain 
Barre’ syndrome. Lumbar puncture is contra indicated when there is increased 
intracranial pressure, infection of the skin over the LP site, severe thrombocytopenia of 
platelet less than 50000 per microlitre and coagulopathy. Headache is common after LP. 
Vomiting and vertigo are other complications observed. It can also be complicated with 
diplopia, brain herniation, epidural, subdural and subarachnoid haemorrhage and 
meningitis.   
 
Early central nervous system (CNS) involvement is often subclinical in 
leukaemia. Lumbar puncture (LP) is a diagnostic, preventive and therapeutic 
intervention for leukemic CNS involvement and relapse. Lumbar puncture is done to 
obtain cerebrospinal fluid and to administer intrathecal drugs. Cerebrospinal fluids are 
evaluated for blast cells to look for CNS infiltration. Chemotherapy protocols for CNS 
infiltrated leukaemia are more extensive whereby more frequent intrathecal 
administrations of drugs are adopted. The other option in CNS infiltration is cranial 
irradiation which is markedly neurotoxic. Since intrathecal chemotherapy is as effective 
as irradiation in prevention of CNS relapse and much safer (Goldsby, Liu et al 2010), it 
is preferred over irradiation (Hasle et al. 1995), (Schrappe et al. 1998). 
 
Cerebrospinal fluid is obtained with a needle inserted between lumbar vertebra 
L3 and L4. Spinal cord ends between L1 and L2. This space lies where an imaginary 
line connecting bilateral posterior iliac crests cross the spine. This space is very small in 
children. The procedure is even more difficult in obese children. Patient lies at lateral 
position with the back at the edge of bed. Plane of the back is perpendicular to the bed. 
Patient is held with supine flexed by tucking both knees to abdomen and slight neck 
flexion. This allows intervertebral space to be wider and more accessible. In bigger 
children LP can also be done in the sitting position. Unless children are not well 
sedated, they are difficult to position properly. Introduction into this small space must 
be precise to avoid hitting vessels and bone that gives a traumatic tap. Traumatic taps 
can introduce blast cells and organisms from blood into cerebrospinal fluid. Inadequate 
sedation is not acceptable because the procedure is painful. Operator may fail to 
perform the procedure because patient is uncooperative keeps moving due to inadequate 
sedation.  
 
 
 
 
1.4 Statement of the problem  
 
Ineffective sedation not only fails these procedures but also end in traumatic 
LPs. Multiple attempts during the procedure creates more anxiety to patient and parents. 
Failed attempts create a vicious circle making subsequent trials even more difficult. 
Patients will be punctured multiple times with many puncture sites and more pain. 
Management of leukaemia in each individual is a long course. It requires practitioners, 
patient and relatives to have a long and close relation between them. Failure of multiple 
attempts might badly affect the relationship between patient, parents and doctors. Our 
experience in the oncology ward where many medical officers are working chronic 
patients and relatives mark practitioners either ‘good’ or bad in terms of performing 
procedures. They look forward for the ‘good’ practitioners to perform procedures on 
them. Provider’s skills and knowledge and how they communicate plays a major role in 
effecting relationship between patients, relatives and paramedics (Liu et al. 2008).  
 
Traumatic LPs are a main concern in treating patients with leukaemia. Leukemic 
patients are immunocompromised. Even though rare it can introduce leukemic cells as 
well as pathogens from blood to a previously normal CSF (Rech et al. 2005). This can 
lead to meningitis and CNS infiltration requiring prolonged antibiotics or intensive 
chemotherapy which could have been prevented with proper sedation.  Properly planned 
procedures and effective sedation helps in decreasing the adverse effects of these 
procedures (Keidan  et al. 2005).  
 
Sedatives can also cause unnecessary adverse effects. These are controlled drugs 
and their preparations are expensive. Currently in the paediatric oncology unit of 
Hospital Universiti Sains Malaysia, 3 drugs are used as add on basis in procedural 
sedation. In order to achieve adequate sedation these three drugs are frequently required 
and at repeated doses. At the time of this study there is no written specific protocol for 
sedation to be used in paediatric haematology and oncology ward of HUSM. Safety and 
efficacy of used drugs are not specifically studied. In order to maintain safety of these 
procedures and to achieve maximum benefit from them evidence based written 
guideline is required. Regular and consistent training programmes of sedation should be 
undertaken for the operators involved (Babl et al. 2010). 
 
Drugs used in PSA have sedative, analgesic and amnesic effects in reducing the 
state of awareness and eliminating perception of pain. The ideal drug is one that 
achieves sedation with lesser dose in a less time without having adverse side effects.  
These drugs may exert adverse side effects like hypoxemia, respiratory depression, 
major airway complications, hypertension, hypotension, bradycardia, poor perfusion, 
vomiting, prolonged sedation and death. Knowledge of these adverse events and close 
monitoring of the patients are the key for safety.  
 
1.41 Current practice 
 
Three sedative regimes are currently used in HUSM paediatric haematology and 
oncology ward. They are midazolam at 0.1mg/kg/dose, pethidine at 1mg/kg/dose and 
ketamine at 1mg/kg/dose. They are administered in additional aliquots as required. 
Atropine (0.01mg/kg/dose) is used in addition to antagonize the parasympathetic effects 
of ketamine. These preparations are made separately in different syringes and require 
few numbers of administrations. Multiple drugs and dosing consume more time and 
human resources but also allow for more errors in drug administration, as it requires 
more calculations and preparations. The errors may arise regarding the drug or the dose. 
Time to regain consciousness would be prolonged when more number of sedatives is 
administered.  
 
The choice of sedation depends on many factors. These include previous 
experience with specific drug to a particular patient including history of developing 
adverse reactions or effective sedation, condition of the patient, drug’s ability to 
decrease patient’s discomfort and induce amnesia.  
 
In the paediatric ward of HUSM, mainly three drugs are used for procedural 
sedation. They are ketamine, midazolam and pethidine. Many centres outside Malaysia 
use other drugs for procedural sedation. These include drugs like propofol, fentanyl or 
mixture of ketamine with propofol (da Silva, et al. 2010, Haque and Fadoo Shah (2010), 
Erden et al. 2009). Others use inhaled gases like nitrous oxide (Ricard et al. 2009). 
Different routes that has been studied include per oral (Bhatnagar, et al. 2008) and 
parenteral methods. PSA can be used in elective as well as non elective procedures. 
 
1.5 Objectives 
 
1.51  Primary objective 
 
Primary objective of this study was to compare the effectiveness and safety of 
combined intravenous midazolam with ketamine against a higher dose of intravenous 
ketamine as the only drug in procedural sedation for lumbar puncture in paediatric 
leukemic patients.  
 
Effectiveness of a drug is the ability of a drug to achieve the desired response 
from the patient. An adverse reaction is an undesired effect produced by a drug at 
standard doses (Goodman and Gilman, 2007). 
 
1.52  Secondary objective 
 
Secondary objectives were to compare the two regimens in terms of; 
1. Time taken to sedate the patient; It was the time taken between 
administration of drug (s) (including flushing with normal saline) and time to 
achieve sedation level by Ramsey Score of 6 
2. Time to complete procedure; It was the time taken between administrations 
of drug (s) (including flushing with normal saline) until completion of 
obtaining CSF. 
3. Time to regain consciousness after sedation; It was time taken between 
administration of drug (s) (including flushing with normal saline) to regain 
consciousness by Aldrete score of at least 8.  
4. Rate of adverse reactions  
 
 
  
1.6 Research protocol 
 
A randomized cross over clinical trial was conducted in paediatric leukemic 
patients. Two regimens were compared as mentioned in the chapter of subjects and 
methods.  
 
1.7  Study site 
 
This study was approved by Research Ethics Committee (Human) of Hospital 
Universiti Sains Malaysia (HUSM), Kelantan, Malaysia (Ref; USMKK/PPP/JEPeM 
((209.3. (09)). It was conducted in paediatric haematology and oncology ward, HUSM. 
The study period was from 1st of June 2009 to 31st December 2010. 
 
Universiti Sains Malaysia (USM) is one of the 4 postgraduate research 
universities in Malaysia. It was established in 1969 as the second university in the 
country and had expanded into more than 20 schools with 13 research centres where 
more than 20,000 students had being enrolled. The health campus of USM was 
established in the state of Kelantan as a distant branch in 1983. Kelantan is one of the 
14 states of Malaysia situated at East Coast of Peninsular, Malaysia. Its population is 
multiracial but majority are Malays. HUSM is a teaching hospital in the health campus. 
HUSM is one of the two government hospitals in Kelantan that cater for a population of 
more than 1.6 million people. Ministry of Higher Education of Malaysia chose USM to 
implement the Accelerated Programme for Excellence (Malaysia’s first APEX 
University) in 2008 because of its development and readiness for changes. It is the 
referral centre for oncology in Kelantan as well as east coast of Malaysia. HUSM 
managed various types of cancers in children and adults. The services provided include 
diagnostic workup and management including chemotherapy, radiotherapy and surgical 
interventions.  These services have been available for more than 20 years.  
 
1.8  Literature review  
 
Many studies are available regarding procedural sedation and anaesthesia in 
paediatric population. Majority are been done in emergency department for 
management of trauma and foreign bodies. Data are also available regarding sedation 
from paediatric oncology settings.  
 
1.81  Ketamine  
 
Ketamine is a derivative of phencyclidine. It was first used in 1965. Since then it 
has been used for anaesthesia in human as well as in animals. Ketamine has been 
thoroughly investigated in different clinical trials during the last two decades. There are 
thousands of references available in Pubmed® database. Dr John Lilly (1915-2001) was 
a world known American physician who experiment ketamine on himself for his 
migraine which he found to be relieved by regular use. Ketamine also is being largely 
abused as a recreational drug. Karl Jansen in his book titled as “Ketamine: dreams and 
realities” has described in detail about its abuse and dangerous effects.  
 
Ketamine is a special sedative that acts as a dissociative anaesthetic. Unlike 
other sedatives, it does not have the continuum in its course of sedation. It separates 
limbic system from thalamoneocortical system so that external stimulus like pain cannot 
be felt. The dissociative state does not cause respiratory depression and airway 
compromise. It is a non competitive N-methyl d-aspartate receptor (NMDA-R) 
antagonist. It alters amino acid synthesis and interferes with function of excitatory 
amino acids such as aspartate and glutamate (Ricci et al.  2010). These amino acids play 
a significant role in analgesia, memory and learning (Muir 2010). Ketamine also binds 
to opioid receptors. It produces a trancelike cataleptic state, analgesia, sedation and 
amnesia.  
 
Half life of ketamine is only 10 to 15 minutes but the metabolites of ketamine 
lasts for another two and half hours. In humans ketamine is metabolized to norketamine 
and dehydronorketamine.  The latter is the main metabolite. The isomer (S) of 
norketamine has a significant clinical activity which is comparable to ketamine that can 
abolish pain (Ebert et al. 1997).  Ninety percent of metabolites are excreted br renal and 
the rest by fecal route. Less than 5% is excreted unchanged in urine. 
 
Ketamine has been used widely in paediatric anaesthesia for different 
procedures with relatively safe history. But its use is not as common as expected (Babl, 
Belousoff et al. 2010). Ketamine is best to used for a short sedation. These include 
minor surgical procedures, lumbar punctures and bone marrow aspiration (Sibley, 
Mackenzie et al 2009). Ketamine also has been used in clinical settings other than 
sedation. This includes management of bronchial asthma (Strube and Hallam 1986) and 
psychiatric disorders such as majoor depression with risk for suicide in adults (Price et 
al. 2009).  
 
 When ketamine is used for sedation, it causes short term adverse effects. These 
include increased intracranial pressure and emergence phenomenon like vivid dreams, 
visual images, hallucinations and delirium. Ketamine also cause increase in intraocular 
pressure, tachycardia, hypertension, vomiting, slurred speech, and disorientation. 
Hallucinations are rare in paediatric age group. These events usually occur after peak 
sedation. Long term adverse effects of ketamine due to recurrent use in subsequent 
number of sedation are not well documented in literature. Short term adverse effects are 
dose related. Children undergoing ketamine should be closely monitored to prevent 
these adverse events (Kruger 1998). 
Respiratory drive and air way protective reflexes are preserved when given 
intravenously at doses of 1.5 to 2mg/kg (Evans et al. 2005). Ketamine can be titrated in 
incremental doses and they are safer than large bolus doses. Some studies mention 
regarding cumulative risk profile especially in patients with renal and liver failure 
(Acworth et al. 2001). It also maintains blood pressure by releasing catecholamine and 
may act as a bronchodilator. This is beneficial in patients with low blood pressure and 
bronchial asthma. 
 
Hypersecretion of saliva is commonly observed after ketamine administration. 
This can be decreased by anticholinergic drugs such as atropine. Ketamine also increase 
sympathetic activity. It should be cautiously used in patients liable to sympathetic 
activity such as increased intracranial and intraocular pressure which might be present 
in leukemic infiltration in such tissues. Emergence delirium is very rare in children but a 
more pleasant emergence phenomenon is more common in this age group (Treston et al. 
2009). Other adverse reactions include nystagmus, agitation, vomiting and myoclonus. 
Unfortunately ketamine does not have an antidote.  
Olney’s lesions were described in rat’s brain when ketamine were used in 
continuous infusion over around 6 hours (Young et al. 2005). These lesions were 
vacuoles found in the neurones of brain when NMDA receptor blockers such as 
ketamine were used.  It is an irreversible injury which is associated with high mortality. 
Whether this is true in humans has not been proven as it requires highly invasive 
methods such as brain biopsy for its evaluation. Indirect methods looking for Olney’s 
lesions do not show any evidence of these lesions. What is known is that ketamine do 
have neurological disturbances in acute phase but clinically there were no permanent 
changes described.  
Ketamine interacts with many other drugs especially sedatives. These include 
sedatives such as benzodiazepines, opioids and barbiturates. When ketamine is added it 
enhances the sedative effects of these drugs. 
Current literature revealed ketamine used intravenously at a dose of 
2mg/kg/dose as a sole agent is effective and safe  for sedations in lumbar puncture and 
bone marrow aspiration done in paediatric oncology units and emergency department 
(Afzal M. Sheikh 2004, Ricard et al. 2009). Ketamine also reduces anxiety related to 
these interventions because of its effectiveness (Ricard et al. 2009). Ketamine has been 
used in paediatric emergency departments safely with minimal adverse reactions such as 
vomiting, adverse behaviours such as anxiety and sleep disturbances (McQueen et al. 
2009). However intravenous ketamine as a single drug for procedural sedation has not 
been studied as a comparison against intravenous midazolam alone or in combination 
with ketamine. To my understanding at the start of this study no study has been done to 
evaluate the effectiveness and safety of our current regimen used in HUSM and there is 
no similar study like this study. Likewise revision of PSA in many centres also shows 
lack of proper guidelines (Borland et al. 2009). We need to develop an effective and 
safe protocol for PSA which adopt least number of drugs and doses.  
 
Ketamine can be administered by different routes. Each route has different 
recommended doses. When given by intravenous route its action lasts for less than an 
hour. Ketamine also has been tried with oral and intramuscular route with success 
(McGlone et al. 2004, Bhatnagar et al. 2008). Per rectal administration of ketamine 
gives enough analgesia but minimal anaesthetic effect (Pedraz et al. 1989, Heinrich et 
al. 2004). Sublingual lozenges have also been shown to have comparable analgesic 
effect (Chong et al. 2009). Maruf and Hossain compared (n= 120 patients) giving 
intravenous ketamine at a dose of 1.5mg/kg with diazepam against combination of 
midazolam and fentanyl. The drug was given for deep sedation by anaesthetists during 
magnetic resonance imaging. Sedation was successful in all patients. In the 60 patients 
who received ketamine with diazepam there were minimal inconveniences recorded 
without adverse effects on vital signs including respiration (Maruf et al. 2010).  
 
Trials have been done in studying the effect of ketamine and midazolam on 
sedation given in different procedures. Many of them were done in emergency 
departments. Some studies used ketamine alone intravenously. Afzal assessed degree of 
sedation and analgesia with needle prick. He also recorded adverse reactions  (Afzal. 
2004). Pruitt compared intramuscular ketamine with intramuscular midazolam during 
repair of facial injuries in emergency department (Pruitt et al. 1995). Pruitt’s results 
show ketamine is safe and effective to be used. His study also showed midazolam 
decrease dysphoria associated with ketamine. Ketamine also has been studied in 
epidural analgesia in post operative patients. The study showed significant decrease in 
pain and use of extra analgesic doses in ketamine group (Chia, Liu 1998). Low dose 
ketamine has been studied combined with very low dose of midazolam and additional 
aliquots of them in paediatric sedation in emergency department (Bleiberg et al. 2007). 
Bleiberg used midazolam intravenously at a dose of 0.05mg/kg with ketamine 0.5mg/kg 
as a starting dose with additional aliquots. It showed 44 percent of patients were 
effectively sedated with a dose of 0.75mg per kg of ketamine. 
 
 
1.82  Midazolam 
 
Midazolam is a water soluble benzodiazepine. It was produced in 1975. It has 
been used widely as a sedative agent in paediatrics during the last 2 decades. 
Midazolam has been used in many elective as well as emergency procedures by 
anaesthetists and non anaesthetists with quite a good safety record (Munro and 
Machonochie 2007).   
 
Midazolam has sedative, hypnotic and amnesic properties without analgesic 
role. These effects vary with the patient’s age, weight, clinical condition and route of 
administration. It can be given by intranasal (Chiaretti et al. 2011), sublingual (Kattoh  
et al. 2008), bucal, oral (Wan et al. 2006) rectal and intravenous routes. It is widely 
distributed and cross blood brain barrier. It is very safe when used alone but in 
combination with other sedatives it might increase the risk of respiratory depression. 
Midazolam can provide deep sedation.  When given intravenously the peak action is 
reached at 5 to 10 minutes and lasts for one to five hours. Ninety seven percent of the 
drug is bound to protein. Extensive hydroxylation occurs in the liver. The primary 
metabolite is alpha-hydroxymidazolam. It has equivalent potency as midazolam.  Most 
of midazolam is recovered in the urine. Metabolites are conjugated by the liver with 
subsequent renal excretion. Amount of drug that is excreted unchanged in the urine is 
non-significant (Ariano RE 1994). 
 
Midazolam has been used effectively in many procedures including in and 
outside hospital care. These include dental procedures (Wan et al. 2006) and 
cardioversion (Notarsetefano et al .2007).  
 
Adverse effects of midazolam include respiratory depression, hypoxia, 
hypotension, vomiting, myoclonic jerks, excessive drooling, paradoxical excitatory 
reactions, allergy, nystagmus, drug interactions, withdrawal effects and tolerance 
(Acworth et al. 2001), (Deitch et al. 2007), (Hohl et al. 2008). Relative 
contraindications of midazolam include shock and brain injury and should not be used 
in hypersensitivity to midazolam.  
 
The advantage of midazolam is that flumazenil can be used effectively as an 
antidote. In the early days flumazenil has been used not only in emergency reversal of 
midazolam effect but also after the procedure to revive the patient from sedation. This 
practice was not proven of use and the recommendation in the literature is not to use it 
as routine for revival (Lewis) 
 
Sedation caused by midazolam is a continuum from mild sedation to general 
anaesthesia. Patients should be intensively observed. There should be a different 
individual other than the person who is performing the procedure to monitor patient’s 
cardiorespiratory status. Failure to recognize worsening of cardiorespiratory status can 
lead to severe hypoxia, hypoxic encephalopathy and death.  
 
Midazolam has been used for procedural sedation for short procedures such as 
lumbar puncture and bone marrow aspiration. It is superior to diazepam because of 
faster sedation and early recovery. This increases compliance with patient and parent 
satisfaction. It has also being seen that midazolam is safer in children than adults (Rosen 
and Rosen 1998).  
 
Midazolam is usually used in combination with other drugs for PSA. As 
mentioned above Maruf has shown that combination of midazolam with fentanyl is safe 
but combination of ketamine with midazolam is more economical (Maruf, Hossain et al. 
2010). Combination of midazolam and ketamine by oral and intramuscular route has 
been compared during sedation for minor surgical procedures. In this study both routes 
has been found to be effective and safe (Bhatnagar et al. 2008). Intranasal midazolam 
has been studied against intravenous ketamine with midazolam. The combined 
intravenous midazolam and ketamine is more superior to intranasal midazolam as a sole 
agent (Acworth et al. 2001).  
 
In a clinical appraisal looking at safety and effectiveness of ketamine and 
midazolam for sedation in emergency department, it has been shown that both were safe 
and effective but ketamine was preferred by physicians and parents (Munro and 
Machonochie 2007).  
 
 1.83  Atropine 
 
Atropine is an anticholinergic. It antagonizes muscarinic actions of 
acetylcholine. In our setup atropine has been routinely used with ketamine in view that 
it reduces cholinergic effects of ketamine such as increased salivation and vomiting 
(Arnett et al. 1984).. Atropine is generally used in medicine for organophosphate and 
nerve gas poisoning.   
 
A randomized placebo controlled double blind study (n=83) has shown a 
significant reduction of hypersalivation and vomiting after atropine administration 
following ketamine anaesthesia (Heinz et al. 2006). Other studies did not show enough 
evidence to support for atropine use in all cases of ketamine sedation (Brown et al. 
2008). Atropine can cause increase in heart rate and augments the positive pulmonary 
function of ketamine (Magoon et al. 1998).  
 
Glycopyrrolate which is a mucuranic anticholinergic reduce secretion from 
salivary glands, tracheobronchial and pharynx. It has been compared with atropine. 
Unlike atropine it does not cross the blood brain barrier. Glycopyrrolate cause less 
tachycardia compared to atropine (Toft and Romer 1987). Glycopyrrolate is never been 
used for this purpose in our unit as a substitute for atropine. 
 
Adverse effects of atropine include a transient rash (Heinz et al. 2006)  
tachycardia, photophobia, fever  (Garg and Sinha 2008) and dryness of mouth. 
Contraindications include previous hypersensitivity to the drug.  
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2.  SUBJECTS AND METHODS 
  
 This study was approved by Research Ethics Committee (Human) of 
Hospital Universiti Sains Malaysia on 08th April 2009 (Ref; USMKK/PPP/JEPeM 
((209.3. (09)). It was conducted in accordance to guidelines on Good Clinical Practice. 
The study site was paediatric haematology and oncology ward, HUSM. The study was 
conducted from 1st of June 2009 to 31st December 2010. Study was supervised by 
paediatrician in oncology unit, paediatrician in pharmacology unit and anaesthetist.  
 
2.1  Subjects 
2.11  Inclusion criteria; 
The following patients were included in the study: 
1. Leukemic patients aged between 6 months to 16 years old 
2. Requires 2 LPs in a 4 weeks interval in the treatment protocol 
3. Consented patient / parent 
2.12  Exclusion criteria 
The following list of patients was excluded from the study. These conditions were 
selected to avoid high risk patients. They also might interfere with sedation and cause 
bias in the results.  
1. Patients undergoing BMA in the same setting before the LP 
2. Patients with relapse of leukaemia  
3. Any structural obstruction to airway  
